These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 24345688)

  • 21. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study.
    Farkouh ME; Domanski M; Dangas GD; Godoy LC; Mack MJ; Siami FS; Hamza TH; Shah B; Stefanini GG; Sidhu MS; Tanguay JF; Ramanathan K; Sharma SK; French J; Hueb W; Cohen DJ; Fuster V;
    J Am Coll Cardiol; 2019 Feb; 73(6):629-638. PubMed ID: 30428398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of a Simple Angiographic Approach With a Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery Score-Based Approach for Left Main Coronary Artery Stenting: A Pooled Analysis of Serial PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease) Studies.
    Lee PH; Lee JY; Lee CW; Kim SO; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005374. PubMed ID: 29311287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-eluting stents or coronary artery bypass grafting for unprotected left main coronary artery disease: a meta-analysis of four randomized trials and seventeen observational studies.
    Li Q; Zhang Z; Yin RX
    Trials; 2013 May; 14():133. PubMed ID: 23782856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
    Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Stenting Versus Bypass Surgery According to the Completeness of Revascularization in Severe Coronary Artery Disease: Patient-Level Pooled Analysis of the SYNTAX, PRECOMBAT, and BEST Trials.
    Ahn JM; Park DW; Lee CW; Chang M; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Lee PH; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2017 Jul; 10(14):1415-1424. PubMed ID: 28728654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Geographical Difference of the Interaction of Sex With Treatment Strategy in Patients With Multivessel Disease and Left Main Disease: A Meta-Analysis From SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) Randomized Controlled Trials.
    Sotomi Y; Onuma Y; Cavalcante R; Ahn JM; Lee CW; van Klaveren D; de Winter RJ; Wykrzykowska JJ; Farooq V; Morice MC; Steyerberg EW; Park SJ; Serruys PW
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous coronary invervention versus coronary artery bypass grafting: a meta-analysis.
    Smit Y; Vlayen J; Koppenaal H; Eefting F; Kappetein AP; Mariani MA
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):831-8.e1-13. PubMed ID: 25467373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-generation drug-eluting stenting versus coronary artery bypass grafting for treatment of coronary chronic total occlusion.
    Jang WJ; Yang JH; Song YB; Hahn JY; Chun WJ; Oh JH; Kim WS; Lee YT; Yu CW; Lee HJ; Gwon HC; Choi SH
    J Cardiol; 2019 May; 73(5):432-437. PubMed ID: 30611686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of diabetes duration on 3-year clinical outcomes following coronary revascularization.
    Gao HY; Zhang EL; Liu QR; Gu HQ; Zhang H; Zheng Z; Yang YJ; Gao RL; Wu YJ
    Coron Artery Dis; 2017 Mar; 28(2):151-158. PubMed ID: 27845997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study.
    Kim H; Kang DY; Ahn JM; Lee J; Choi Y; Hur SH; Park HJ; Tresukosol D; Kang WC; Kwon HM; Rha SW; Lim DS; Jeong MH; Lee BK; Huang H; Lim YH; Bae JH; Kim BO; Ong TK; Ahn SG; Chung CH; Park DW; Park SJ;
    JACC Cardiovasc Interv; 2023 Oct; 16(19):2412-2422. PubMed ID: 37821187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
    Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
    JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of chronic kidney disease on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or drug-eluting stents.
    Pan Y; Qiu Q; Chen F; Li X; Yu X; Luo Y; Li Q; He J; Gao Y; Zhang X; Ren X
    Coron Artery Dis; 2016 Nov; 27(7):535-42. PubMed ID: 27269882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
    Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trials.
    Vardi M; Burke DA; Bangalore S; Pencina MJ; Mauri L; Kandzari DE; Leon MB; Cutlip DE
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1031-8. PubMed ID: 23737390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-Eluting Stent Versus Coronary Artery Bypass Grafting for Diabetic Patients With Multivessel and/or Left Main Coronary Artery Disease: A Meta-Analysis.
    Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Angiology; 2019 Sep; 70(8):765-773. PubMed ID: 30995117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial.
    Park DW; Ahn JM; Park H; Yun SC; Kang DY; Lee PH; Kim YH; Lim DS; Rha SW; Park GM; Gwon HC; Kim HS; Chae IH; Jang Y; Jeong MH; Tahk SJ; Seung KB; Park SJ;
    Circulation; 2020 May; 141(18):1437-1446. PubMed ID: 32223567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term (10-Year) Outcomes of Stenting or Bypass Surgery for Left Main Coronary Artery Disease in Patients With and Without Diabetes Mellitus.
    Lee K; Ahn JM; Yoon YH; Kang DY; Park SY; Ko E; Park H; Cho SC; Park S; Kim TO; Lee PH; Lee SW; Park SW; Park DW; Park SJ
    J Am Heart Assoc; 2020 Apr; 9(8):e015372. PubMed ID: 32310027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention.
    Krenn L; Kopp C; Glogar D; Lang IM; Delle-Karth G; Neunteufl T; Kreiner G; Kaider A; Bergler-Klein J; Khorsand A; Nikfardjam M; Laufer G; Maurer G; Gyöngyösi M
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1029-39. PubMed ID: 24403120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.